Clinical Trials Directory

Trials / Not Yet Recruiting

Not Yet RecruitingNCT06745362

Weight Reduction With the Low-Insulin-Method - Self Monitoring of Breath Acetone

Status
Not Yet Recruiting
Phase
N/A
Study type
Interventional
Enrollment
42 (estimated)
Sponsor
West German Center of Diabetes and Health · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The goal of this clinical trial is to learn if lifestyle intervention with information about ketosis state supports weight reduction in overweight adults. Researchers will compare an App-based lifestyle intervention with self-monitoring of breath acetone vs. lifestyle intervention alone. Participants will: Get a lifestyle intervention via the LIM-App for 12 months. Report body weight.

Detailed description

Background: Overweight and obesity are an increasing problem. Therefore, the Low-Insulin-Method was developed to support overweight and obese people in weight loss. Method: In a randomized controlled clinical trial, the effect of the lifestyle intervention program 'Low-Insulin-Method', delivered by the Low-Insulin-App including low-carb diet, physical activity, self monitoring of weight, and self-monitoring of breath acetone (SMBA) is examined compared to a control group without information about ketosis level. Weight change will be compared after 3 and 12 months. Objective: The aim is to develop a training and counseling program for overweight or obese individuals with diabetes risk or type 2 diabetes, which can be used both for primary and for tertiary prevention of overweight-related diseases.

Conditions

Interventions

TypeNameDescription
OTHERself-monitoring of breath acetoneParticipants perform self-monitoring of braeth acetone in order to get information about their ketosis state.
OTHERlifestyle-intervention via LIM-AppParticipants are offered a lifestyle intervention via LIM-App.

Timeline

Start date
2026-01-01
Primary completion
2027-12-31
Completion
2027-12-31
First posted
2024-12-20
Last updated
2025-06-29

Locations

1 site across 1 country: Germany

Source: ClinicalTrials.gov record NCT06745362. Inclusion in this directory is not an endorsement.